Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

Treatment with Brukinsa (zanubrutinib) demonstrated better efficacy compared with Imbruvica (ibrutinib), as well as an improved overall safety and tolerability profile in patients with relapsed or ...

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval ...

On World Cancer Day 2025, learn how cancer affects different age groups in India. Oncologists share insights on early detection, prevention, and the importance of regular screenings.

Dwyane Wade reflected on having a cancerous tumor removed from his kidney as well as 40 percent of the organ itself after ...

AbbVie Inc. (NYSE:ABBV – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $175.65, but opened at $187.30. AbbVie shares last traded at $189.08, with a volume ...

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...

Gastrointestinal illness outbreaks on Princess Cruises and Viking ships sickened nearly 150 people. Among 1,894 guests aboard Princess’ Coral Princess ship, 59 reported being ill during its ...

Yescarta (axicabtagene ciloleucel) has been approved as a treatment for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma ...

Gastrointestinal diseases are those that affect any section of the gastrointestinal tract, from the oesophagus to the rectum, and the accessory digestive organs liver, gall bladder and pancreas ...

Women are more likely than men to develop long COVID, a new study finds, with the highest risk in women ages 40 to 54. Women ...

Although CAR T-cell treatment can lead to clinical remissions in patients with hematological malignancies, relapse rates ultimately remain high. Previous research has found that T memory stem cell ...